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ABSTRAK 
 
PERUBAHAN RESEPTOR GABA DAN MODIFIKASI IMMUNOREAKTIVITI 
IP3 & BDNF-TrkB DALAM KULTUR NEURON EPILEPTOGENIK 
HIPPOCAMPAL TIKUS YANG TERINDUKSI OLEH KAINATE ASID 
 
PENGENALAN: Penyakit epilepsi adalah keadaan biasa yang berlaku dalam 
kira-kira 50 juta orang di seluruh dunia. Serangan epilepsi adalah keadaan sementara 
yang berlaku akibat daripada aktiviti berlebihan yang tidak normal di dalam otak. Kajian 
menunjukkan reseptor GABAAR menyokong peranan BDNF-TrkB sebagai faktor 
pelindung neuron dalam hippocampus dan BDNF-TrkB yang mencetuskan salah satu 
isyarat IP3R yang terlibat dalam serangan epilepsi.  Kajian terdahulu memberi tumpuan 
kepada Teknik in vivo dan Teknik pengkulturan secara in vitro. Walau bagaimanapun, 
kajian semasa menunjukkan terdapat hubung kait yang tidak jelas, oleh itu keputusan 
daripada kajian semasa boleh dilaksanakan melalui pengkulturan neuron hippocampal 
tikus yang diekstrak secara in vitro.    
 
OBJEKTIF: Kajian ini bertujuan untuk mengkaji perubahan reseptor GABAA 
(GABAAR), faktor neurotropik otak (BDNF), reseptor kinase Tyrosine B (TrkB) dan 
reseptor Inositol 1, 4, 5 trifosfat (IP3R) dalam neuron hippocampal normal dan 
epileptogenic disebabkan oleh asid kainik. 
 
xxii 
 
METODOLOGI: Dalam kajian ini, kaedah pencetus sawan secara kimia, asid kainik 
(KA) telah digunakan untuk melibatkan kesan sawan di dalam neuron hippocampus 
tikus. Embrio hari ke-18 (E-18). Sel neuron daripada tikus E-18 telah dikultur 
berdasarkan kaedah yang telah  dioptimumkan dengan menggunakan kepingan kaca 
bersalut poly-L-lysine (Todd et al., 2013). Pada hari ke- 14 dengan mengunakan teknik 
in vitro sel kultur neuron akan dirawat dengan 0.5µM KA selama 30 (KA30), 60 (KA60) 
dan 90 (KA) minit. Neuron yang normal dan neuron yang dirawat dengan KA masing-
masing akan menjalani pemeriksaan bagi daya tahan sel, pertubuhan neurit dan penilaian 
immune kimia. 
 
KEPUTUSAN: Hasil kajian menunjukkan receptor GABAA mengandungi 
komponen α1  dan BDNF yang dirawat KA adalah tidak signifikan berbanding 
pengkulturan sel neuron yang dirawat secara normal. Reseptor TrkB yang diberi rawatan 
menunjukkan kadar penurunan yang signifikan (F (3, 8) = 8.761, p <0.01). Pada KA30, 
KA60 dan KA 90 menujukkan penurunan yang signifikan jika dibandingkan dengan 
kumpulan kawalan iaitu kumpulan yang tidak dirawat dengan KA. Selepas rawatan 
mengunakan KA, IP3R juga meningkat dengan ketara jika dibandingkan dengan 
kumpulan kawalan (F (3, 8) = 6.954, p < 0.05). 
 
   KESIMPULAN: Rawatan KA dalam pengkulturan sel neuron hippocampal 
menunjukkan peningkatan ketara dalam ekspresi reseptor TrkB (reseptor BDNF) dan 
IP3R, manakala imunoreaktiviti BDNF dan reseptor GABAAR yang mengandungi 
xxiii 
 
komponen α1 menunjukkan kadar penurunan yang tidak signifikan. Secara 
keseluruhannya, kajian ini menunjukkan bahawa rawatan mengunakan KA ke atas sel 
neuron hippocampal tikus secara  in vitro mempengaruhi epileptogenesis dan melibatkan 
perubahan dalam ekspresi reseptor GABAA mengandungi komponen α1, BDNF, TrkB 
dan IP3R. 
Kata Kunci:  GABA, GABAAR, GABAA R yang mengandungi α1, BDNF TrkB, IP3R, 
Kainic asid, Epileptogenik. 
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ABSTRACT 
 
Changes of GABA Receptor and Immunoreactivity Modification of IP3 & BDNF-
TrkB in KA-Induced Rat Epileptogenic Hippocampal Neuronal Culture 
 
INTRODUCTION: Epilepsy seizure is a common condition occurring in 
approximately 50 million people worldwide. Epilepsy seizure is a transient occurrence 
of sign and or symptoms due to abnormal excessive or hypersynchronous activity in the 
brain. Studies showed GABAAR supporting the role of BDNF-TrkB as a neuroprotective 
factor in the hippocampus and BDNF-TrkB triggers one of the downstream signalling 
IP3R which is involved in epilepsy seizure.  However, past studies focus on in vivo and 
in vitro organotypic hippocampal slices culture. It is unclear whether the findings of the 
current study would extrapolate in vitro dissociated primary rat hippocampal neuron 
culture.  
 
OBJECTIVE: To study the changes of γ-Amino butyric acid A receptor 
(GABAAR), Brain derived neurotrophic factor (BDNF), Tyrosine kinase receptor B 
(TrkB) and Inositol 1, 4, 5 triphosphate receptor (IP3R) in normal and epileptogenic 
hippocampal neuron. 
 
METHOD: In this study, chemo-convulsant method, kainic acid (KA) induced 
seizure applied to (E-18) rat hippocampus neuron. The E-18 rat hippocampus neuron 
xxv 
 
was cultured based on the optimised method by using poly-L-lysine coated glass 
coverslips (Todd et al., 2013). The day in vitro (DIV), 14 culture neurons induced with 
0.5μMKA for 30 (KA30), 60 (KA60) and 90 (KA)minutes respectively.  The normal and 
KA treated neuron underwent cell viability, neurite outgrowth density assessment and 
immunocytochemistry assessment respectively.  
 
RESULTS:  Finding showed no significant effects of GABAA α1-containing 
receptors (GABAA α1 containing R )and BDNF of the KA treatment to the normal 
neuron culture. The TrkB receptor was significantly decreased by the treatment (F (3, 8) 
= 8.761, p < 0.01). The KA30, KA60 and KA 90 were significant decreased compared to 
the control group with no KA treated culture. The IP3R was elevated significantly y the 
treatment of KA (F (3, 8) = 6.954, p < 0.05) . 
 
CONCLUSIONS: The KA administration on hippocampal neuron culture 
showed an increase expression in the TrkB (BDNF receptor) and IP3R significantly 
whereas, the immunoreactivity of BDNF and GABAA α1 containing R showed a 
decreased expression that is not statistically significant. Altogether, our study showed 
that KA administration on in vitro rat hippocampal neuron induces epileptogenesis 
which, results in changes in the GABAA α1 containing R, BDNF, TrkB and IP3R. 
 
Keyword: GABA, GABAAR, GABAA α1 containing R, BDNF, TrkB, IP3R, Kainic acid 
1 
 
CHAPTER 1 
 
 
INTRODUCTION  
1.0 Epilepsy and seizure 
According to International League Against Epilepsy (ILAE) and the International 
Bureau for Epilepsy (IBE), epileptic seizure is a transient occurrence of sign and or 
symptoms due to abnormal excessive or hypersynchronous neuronal activity in the 
brain. Meanwhile, epilepsy is a disorder of the brain characterized by an enduring 
predisposition to generate epileptic seizure and by the neurobiological cognitive, 
psychological and social consequences of this condition. According to Fisher (2005), to 
be defined as epilepsy it requires the occurrence of at least one epileptic seizure. 
Currently, statistic shows approximately 50 million people live with epilepsy worldwide, 
with the estimation 2.4 million new patients are diagnosed with epilepsy every year 
(World Health Organization, 2017). Considering the total world population, less than 
1% having epilepsy and about one-third of patients are detected with refractory epilepsy 
where the seizures are not controlled by two or more appropriate antiepileptic 
medications or other therapies (Stafstrom & Carmant, 2015). 
Although the term of epilepsy and seizure are often to be misunderstood, seizure 
is difference than epilepsy. Seizures can be divided into three categories; generalised, 
focal and epileptic spasm according to ILAE most recent publication on classification of 
epileptic seizures and epilepsies (epilepsy syndrome) in 2010.  Generalised epileptic 
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seizures are conceptualised as a seizure originating at some point within and bilateral 
distributed network (Berg et al., 2010).  An individual seizure onset can be localised 
which the location and lateralization are inconsistent from one seizure to another. 
Whereas, focal epilepsy seizures are conceptualised as a seizure originating within 
network limited inside one hemisphere and the site of onset is consistent (Berg et al., 
2010). Focal epilepsy seizures are depending on the cortex involved, for instance, 
seizure onset at temporal lobe are often results dyscognitive (Stafstrom & Carmant, 
2015).  Dyscognitive is a condition when consciousness is impaired during focal seizure, 
patient unable to responds verbal or tactile stimuli and exhibit uncoordinated activity 
such as paraesthesia (Stafstrom & Carmant, 2015).  The third category of seizure is 
epileptic spasm, which is relatively uncertain. Epileptic spasms are manifested by 
sudden extension or flexion of extremities, held for several seconds, and they recur in 
clusters for example, sudden extension of both arms and flexion of the neck (Berg & 
Millichap, 2013).  These epilepsy syndromes are detrimental, meaning it requires 
continuous explorations to find a resolution to relieve epilepsy’s patient. Numerous of 
researches have been conducted on animal to study the onset of seizures in human and 
understanding the mechanism underlying seizure. 
1.1  Animal model in epilepsy studies   
Among the approaches are different types of animal model, which have been 
used in studies relating to epilepsy for decades. Animal model is essential in elucidate 
mechanism underlying epilepsy seizures with the aims to mimic the mechanism of 
epilepsy in human.  Generally, animal models are used in epilepsy studies involving of 
epileptic seizures rather than model of epilepsy considering the fact that epilepsy is 
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characterized by occurrence of epilepsy seizure more than one time, in which an acute 
seizure is electrically induced in normal non-epileptic animal unable to represent a 
model of epilepsy (Löscher, 2011). Other than that, there are more genuine models of 
epilepsy such as genetic animal model, which are mutated or transgenic with 
spontaneously recurrent seizures exhibiting closely similar seizure symptoms in human 
epilepsy (Löscher, 2011). On the other hand, induction of seizures in normal animals or 
commonly known as epileptogenesis can be induced by chemical substances such as 
pilorcarpine and kainic acid (KA) as well as electrical or kindling technique (Löscher, 
2011). Epileptogenesis refers to a process in which the occurrences of spontaneous 
seizure induced by brain-damaging insults that triggers a cascade of molecular and 
cellular changes (Pitkänen, & Lukasiuk, 2009). Chemical induced seizure is known as 
chemoconvulsant while electrical induced seizure is referred as electrical stimulation. 
Both chemoconvulsant and electrical stimulation animal models are used specifically 
based on the experimental method.  
Pilocarpine and KA are chemoconvulsants and have been used to generate 
spontaneous recurrent seizures. Pilocarpine is a muscarinic acetylchlorine receptor 
agonist, which is usually used to induce seizure in limbic via systemic or intracerebral 
injection of pilocarpine, whereas KA is a glutamate analogue and its causes neuronal 
depolarization and seizures preferentially targeting the hippocampus through systemic or 
intracerebral administration (Kandratavicius et al., 2014). Both pilocarpine and KA 
produce neuronal damage without sophisticated instruments.  Pilocarpine and KA are 
exhibited similar electroencephalographic features and the neuropathological alteration 
in rodents (Lévesque, Avoli & Bernard, 2016). However, pilocarpine model gives more 
intense damage than KA model and KA is favorable to be used as initial screening of 
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neuroprotective drug (Covolan and Mello, 2000). Pilocarpine-induced seizure is often 
used to examine the relationship of between mossy fiber synaptic reorganization a 
spontaneous seizure activity whereas KA-induced seizure is targeting hippocampus 
(Kandratavicius et al., 2014; Reddy & Kuruba, 2013). A major drawback of the KA is 
the KA model is variable sensitivity of rat of different strains, sex, age and weight to KA 
where aged rat is more vulnerable to KA with high potency towards KA with greater 
neuronal damage (Reddy & Kuruba, 2013). Another limitation is KA has direct 
excitotoxic action making it difficult to differentiate direct neuronal damage from 
seizure-induced neuronal damage and it is less ideal for anticonvulsant for SE because 
not all effective drugs are truly effective in KA-induced model (Reddy & Kuruba, 2013).  
 If compared to KA-induced model, kindling is the most studied model of 
electrical stimulation. In this method, the emergence of spontaneous seizure and the 
establishment of permanent epileptic states are culminated through electrical stimulation 
in a specific brain region (Kandratavicius et al., 2014). This model has advantages in 
reproducing epileptogenic features in the intact brain with low mortality and high 
reproducibility (Kandratavicius et al., 2014). However, seizure modeling by electrical 
stimulation does not provide cell-type specific in the brain and this stimulation protocols 
could be costly and laborious when used for chronic studies (Kandratavicius et al., 
2014).   
In in vitro perspective, KA-induced model is more appropriate to be used. KA-
induced seizures preferentially targeting hippocampus and its effect onto seizure is less 
intense compared to pilocarpine this allows our preliminary study on in vitro model from 
missing potential components. Moreover, KA has validated effect from previous studies 
and this perhaps contribute a better understanding of the molecular, cellular and 
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pharmacological mechanism underlying epileptogenesis and ictogenesis (Lévesque, & 
Avoli, 2013). Therefore, KA-induced seizure model is preferentially to be used in 
neuron culture.  
1.1.1  KA-induced model 
KA-induced model or KA model is a tool for seizure studies due to manifestation 
of symptoms such as behavioral changes of rodents, oxidative stress, glial activation, 
and production of inflammatory mediators, endoplasmic reticulum stress, mitochondrial 
dysfunction and neuronal degeneration in the brain of rodents (Nadler, 1981; Robinson 
& Deadwyler, 1981; Sairazi et al., 2015). KA is a L-glutamate and an agonist of 
ionotropic KA receptors (Lévesque and Avoli, 2016). KA was isolated and extracted in 
the early 1950s from red algae (Digenea simplex). KA model is practically used to 
induce epileptogenic symptoms in experimental animal model. Experimental models 
that administrated with KA exhibit seizure, behavioral changes, oxidative stress, and 
production of inflammatory mediator (Sairazi et al., 2016). KA is commonly used as a 
model of epilepsy either in neuronal culture model or in vivo model (Lévesque & Avoli, 
2016; Pal et al., 2001). KA essential in experimental models and it was found that 
occurrences of epileptogenesis is due to the alteration of Ca2+ homeostatic mechanism 
(Sun, 2001).  Alteration of Ca2+ happened when KA bound to the kainate receptors 
excessively and over-activation of kainite receptor produces neuronal membrane 
depolarization causes excessive influx of Ca2+ into the neurons which is called 
glutamatergic excitotoxicity (Bevinahal et al., 2014; Halopainen, 2004). Eventually, 
excessive influx of Ca2+contributes to neuronal insult and neuronal death (Bevinahal et 
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al., 2014; Halopainen, 2004, Sun et al., 2001; Wang et al., 2006; Zheng et al., 2010). 
Therefore, dose of KA application to the neuron is critical as the effects of KA-induced 
seizure are detrimental.  
Dosage of KA application is a critical factor in this model as the different dosage 
would results in varies of severity of seizure symptoms in the experimental model. Low 
dosage of KA is always recommended. As in, the conduction of screening for the dosage 
and time of KA exposure are certainly needed to be considered to study the changes in 
hippocampal neuron culture. Based on Järvelä (2011) experiment, immature (P6, P9, 
Wistar and Sprague Dawley rat) and mature juvenile (21-day old Sprague Dawley rat) 
organotypic hippocampal brain slices were administrated with three different 
concentrations of KA, which are at concentrations of 1, 2, and 5 μM.  Results 
demonstrated 1 μM was generally mild; 2 μM is mild to moderate and 5 μM is moderate 
to severe to organotypic hippocampal brain slices. These suggested that lower doses of 
KA should be used to control the mortality issue in immature rats (Järvelä (2011).  
Kaneko and colleagues (2015) also used KA to induced early-stage epilepsy in in vitro.  
A range of 1.25 nM to 125 μM KA was administrated onto day-3 cultures primary 
neuronal cells for 3 days. The half maximal inhibitory concentration (IC50) was 5 μM 
KA, where the KA was found effectively inhibiting seizures function in the primary 
neuron culture (Kaneko et al., 2015).  Therefore, KA dose is varying to different 
experimental approach to exhibit seizure. 
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1.2  Epilepsy and the responsible receptors  
 Previous works in epilepsy studies have demonstrated that ionic changes in the 
excitatory/inhibitory balance of the brain play a crucial part in epilepsy (Kim & Yoon, 
2017). For example, gamma-aminobutyric acid or commonly known as GABA is the 
principle inhibitory neurotransmitter in the cerebral cortex which maintaining the 
inhibitory tone that counterbalances neuronal excitation by binding on GABAA receptors 
(GABAARs). When this balance is disturbed, seizures which followed by epilepsy may 
occur. In addition to GABA and GABAARs interactions, brain-derived neurotrophic 
factor (BDNF) and its receptor tyrosine kinases (TrkB), which are essential in 
influencing neuronal survival, differentiation, synaptogenesis and maintenance (Webster 
et al., 2006), also involve in the limbic epilepsy animal model (Danzer, 2004). Mice 
with neuron-specific TrkB deficient and transgenic mice with overexpressing BDNF 
demonstrated that TrkB activation is critical for downstream signaling for 
epileptogenesis (Croll et al., 1999; He et al., 2004). A series of evidence also shows 
inositol (1,4,5)-trisphosphate receptors or IP3R in hippocampus is important in 
regulating the intracellular Ca2+ as in modulating anticonvulsant and epileptogenic effect 
and in mediating injury during seizures (Nagarkatti et al., 2008). In transgenic mice with 
deficient of phenotype of IP3R in cerebellum and brain stem exhibited cerebellar ataxia 
and seizure like posture at postnatal 10 days and this mouse have short life span it die 
within 3 - 4 weeks after birth (Hitsatsune & Mikoshiba, 2017).  
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1.2.1  GABAergic mechanisms 
GABAAR which is the main inhibitory receptor is one of the ion channels that 
had been widely used to study epilepsy. Generally, GABAAR is made up of five 
subunits to form a pentameric structure with the chloride channel in the middle of the 
complex. The subunits are group into different group which comprising 19 members; 
α1-6, β1-3, γ1-3, δ, ε, θ, π and ρ1-3 (D’Hulst & Kooy , 2007; Tsunashima et al., 1997).  
GABAAR can be activated by GABA which rapidly removed by uptake into both glia 
and presynaptic nerve terminal and then catabolized by GABA transaminase that enable 
the neuron to counterbalance the flows of ions rapidly during the neuronal excitation 
(Kim & Yoon, 2017).  
The various combinations of different subunits produce specific traits that are 
localized to different brain regions with different pharmacological properties (Olsen & 
Sieghart, 2009). In the body, GABAARs present in the cortex, heart, lung and stomach, 
however they can be found relatively higher in the certain places such as renal medulla, 
cortex, left ventricle, aorta and pancreas. The mRNA of GABAAR in the cortex was 
found different from mRNA of GABAAR at other organs of the body, researcher also 
found out that GABAAR subunit α1, β1, β3 and γ3 are exclusively present in the brain 
only (D’Hulst & Kooy, 2007). Therefore, GABAAR is one of the main receptor in 
neuronal study to elicit the functional, morphology as well as the sites for therapeutic 
agent (D’Hulst & Kooy, 2007; Kim & Yoon, 2017; Nishimura et al., 2005; Tyagi et al., 
2007).  
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At early stage of human development, GABAAR exhibited as excitatory but later 
it transforms to inhibitory at the point of maturity as discussed by Ben-Ari (2006) in his 
review stated that GABAAR is excitatory at early developmental stages, low density of 
glutamatergic synapse is insufficient to result, a high-frequency oscillation that has long-
term consequence without the GABA act as a paracrine factor. Moreover, researchers 
also found GABAAR functions as an excitatory neurotransmitter-triggers membrane 
depolarization, action potential and open Ca2+ channel plasma membrane at early of 
neuronal development (Obrietan, Gao & van den Pol, 2002).  
In mature brain, GABAAR activation leads to Cl
− influx, and results 
hyperpolarization in the neuron. According to Senargor, (2010) tonic GABA binds to 
low affinity extra-synaptic GABAAR. This is due to the low expression of KCC2 pump 
and high expression of the NKCC1 pump. The KCC2 function is controlling the 
trafficking of cation-Cl− and the KCC2 shift the GABAergic receptor from excitation to 
inhibitor as maturation progress (Blaesse et al., 2009). The GABAergic transition from 
excitation to inhibition is activity-dependent. An initial in vitro study reported that 
GABAergic activity regulates its own switch from excitation to inhibition (Ganguly et 
al., 2001). Along the maturation of KCC2, low threshold T-type Ca2+ channels are 
opened, resulting in Ca2+ influx and intracellular events that will eventually lead to 
neurite extension. At late maturational stages, glutamatergic signaling has developed and 
GABA may act in together with NMDA and AMPA neurotransmission, resulting in 
stronger depolarization and the opening of high-threshold L-type Ca2+ channels. This 
will result in stronger Ca2+ influx, which may be important for triggering downstream 
intracellular events that are responsible for the late phases of neurite growth (Sernargor, 
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2010). This process will come to an end when synaptic inhibition mature through 
changes in the composition of the GABAAR subunits and reversal of the Cl
− gradient, 
leaving the possibility for plastic remodeling of the existing neurite network by the 
dynamic balance of neuronal activity resulting from hyperpolarizing GABA and fully 
developed glutamatergic signaling. 
1.2.2  BDNF 
Previous studies showed that brain derived neurotrophic factor or BDNF 
interacts with GABA transport as well as GABAARs in nerve terminals and neuronal 
cultures. For instance, Obrietan and colleagues (2002) demonstrated that GABAAR 
activation triggered BDNF expression and pre-synaptically facilitated GABA release 
thus forming a positive feedback loop during the maturing of BDNF at early 
development, where GABA stimulates BDNF expression and BDNF facilitates the 
synaptic release of GABA (Obrietan et al, 2002). MAPK cascade and transcription 
factor CREB should be coupled and they reviewed NT3 exerted an excitatory 
modulation of GABA activity, but, only during the development period when GABA 
function as an excitatory neurotransmitter (Liu et al., 1999). Jagasia and the team (2009) 
showed GABA-mediated depolarization was also involved in the phosphorylation of 
CREB during the first 2 weeks of development. The BDNF was then envisaged CREB 
signaling may eventually converge onto the BDNF pathway and act as an effector of 
depolarizing GABA effect on neurite outgrowth and dendritic length (Chan et al., 2008). 
In different work by Sernagor and colleagues (2010), they deduced that at early 
development of neuron the release of BDNF are depends on GABAergic depolarization, 
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however the synthesis of BDNF mRNA was found to reduce in response to GABAergic 
activity in the mature neuron (Sernagor et al., 2010). Deprivation of BDNF signaling 
results in dendrite growth impairment in newborn neurons during development and 
eventually converge onto BDNF pathway for the dendritogenesis effect, due to the 
postnatal depletion of BDNF was impactful to dendrite branching, length and 
complexity (Berghuis et al., 2006; Giusi et al., 2009; Sernagor et al.,2010). 
BDNF is ubiquitous in central nervous system and relatively high in the 
hippocampal formation and cerebral cortex. BDNF is a part of a general mechanism for 
activity-dependent modification of synapses in developing and adult nervous system. In 
rats, BDNF level is expressed highly in the early and the postnatal period and throughout 
the life of rodent (Sakharnova, 2012; Webster et al., 2006). Gonzalez (2014) reviewed 
that BDNF is at the highest level in the hippocampus, where its concentration is 
increased approximately 20 times higher during the first week of young adulthood. This 
is revealed the level of neurotrophic is growing rapidly in the early development of 
hippocampus. BDNF increases the survival and promoting the growth of dendrite in the 
brain.  
BDNF is a member of ‘neurotrophin’ family of the neurotrophic factor. The 
amino acid sequence of BDNF have a strong homology with nerve growth factor, 
neurotrophin first described due to its trophic (survival and growth promoting) effects on 
the sensory and sympathetic system such as neurotrophin-3 and neurotrophin-4/5 
(Binder, 2004). BDNF expression also can be promoted by the exercise where, Sleiman 
and his colleagues (2016) concluded that BDNF, a trophic factor that supplementary to 
cognitive improvement and relieve depression and anxiety. Besides, BDNF also being 
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studied in peripheral taste (Huang & Krimm, 2010) and BDNF contributed in 
mechanical nociception production after nerve injury in the spinal cord (Wang et al., 
2009).  
 
1.2.3. BDNF and TrkB  
Along with its receptor; tyrosine kinases (TrkB), BDNF influence neuronal 
survival, differentiation, synaptogenesis and maintenance (Webster, Herman, Kleinman 
& Weickert, 2006). BDNF-mediated TrkB activation was involved in the limbic 
epilepsy animal model (Danzer, 2004). The TrkB activation would trigger three 
downstream signaling pathways; Phosphatidyl inositol3-kinase (PI3K)- , Phospholipase 
Cγ (PLCγ) and Mitogen-activated protein kinases/extracellular signal-regulated kinases 
(MAPK/ERK) (Tanaka et al., 1997; Matthew & Hablitz, 2008; Yoshii & Constantine-
Paton, 2014). Yoshii and Constantine-Paton (2014) found out that TrkB regulates 
postsynaptic localization of PSD-95 through three downstream pathways, MAPK/ERK 
can regulate transcription through CREB and other transcription factors whereas 
MAPK/ERK and PI3K-AKT pathway play a major role in translation. The post-
translational modification is regulated by BDNF-TrkB signaling via PLC-PKC. These 
mechanisms are likely to regulate BDNF-dependent long-term plasticity.  
Yang and colleagues (2016) suggested PLCγ is the pathway involved in 
epileptogenic seizure. Additionally, this PLCγ pathway generates inositol triphosphate 
(IP3) thru activation by TrkB, which mobilizes intracellular Ca
2+ from the endoplasmic 
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reticulum (Tanaka et al., 1997; Krishnakumar, 2009; Yang et al., 2016). The 
mobilization of Ca2+ ions are eventually result in suppression of GABAAR and leads to 
epileptogenic seizure (Heinrish, 2011; Mathew & Hablitz, 2008).  
 
1.2.4 IP3R and epilepsy 
IP3R was found higher in epileptic cerebral cortex compare to normal cortex 
(Krishnakumar, 2009). The IP3R are the intracellular Ca
2+ release channels that play a 
key role in Ca2+ signaling in cells localized predominately in the endoplasmic reticulum 
of all cell type (Bezprozvanny et al., 2005; Foskett et al., 2007). IP3 are commonly 
known to regulate membrane trafficking, glucose metabolism and signal transduction 
(Yang et al, 2016). It plays a significant role in postsynaptic transmission, such as 
synaptic transmission. The IP3R is a secondary messenger molecule for release Ca
2+ 
from intracellular stores when IP3 is bound to the   endoplasmic reticulum (Hitsatsune & 
Mikoshiba, 2017). According to Nagarkatti and colleagues (2008), IP3R in hippocampus 
is important in regulating the intracellular Ca2+ as in modulating anticonvulsant and 
epileptogenic effect and in mediating injury during seizures. In transgenic mice with 
deficient of phenotype of IP3R in cerebellum and brain stem exhibited cerebellar ataxia 
and seizure like posture at postnatal 10 days and this mouse have short life span it die 
within 3 - 4 weeks after birth (Hitsatsune & Mikoshiba, 2017). Thus, the IP3R is 
essential to modulate the cell signaling and cell survival.  
14 
 
1.3  Rational of the study 
Previous works show BDNF’s mRNA expression increased after KA 
administration (Bevinahal et al., 2014; Ernfors et al., 1994; Isackson et al., 1991; Kokaia 
et al., 1995). In addition to that, a study conducted by Lähteinen and colleagues (2002) 
on BDNF transgenic mice with truncated TrkB receptor demonstrated that seizure 
behavior was reduced in response to KA. Also, Koyama and the team (2005) found out 
that activity-induced BDNF release and Trk receptor activity protected the hippocampus 
from developing of hyper-excitable circuit by activating GABAAR supporting the role of 
BDNF as neuroprotective factor in the hippocampus. Therefore, it is important to 
examine the changes of GABAAR, BDNF, TrkB and IP3R in normal and KA-induced 
epileptogenic neuron to elucidate the mechanism of epileptogenesis and apparently 
relieves patients who suffered from seizure by provide therapeutic target for anti-
epileptic drug research. 
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1.4  Objective and hypothesis  
 1.4.1  Hypothesis. 
 Changes of GABAA receptor and immunoreactivity properties of BDNF, TrkB receptor 
and IP3R may occur in the rat epileptogenic hippocampal neuron culture.  
1.4.2  Research objective  
1.4.2.1 General objective 
To study the changes of GABAAα1 containing Receptor, BDNF, TrkB and IP3R in the 
normal and KA-induced rat epileptogenic hippocampal neuron culture. 
1.4.2.2 Specific objective 
1. To optimize time of KA administration on E-18 Rat hippocampus neuronal 
culture.  
2. To assess the expression of immunoreactivity GABAAα1 containing Receptor, 
BDNF, TrkB and IP3R in normal and epileptogenic hippocampal neuron treated 
with KA. 
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CHAPTER 2 
 
 
MATERIALS AND METHODS 
2.0 Materials 
2.0.1 Primary Neuron culture 
Primary Rat Hippocampal Neuron (C/N: A104841-01) was purchased from 
Gibco™, USA. Primary Rat Hippocampus Neurons were isolated from day-18 Fisher 
344 rat embryos (E-18) and cryopreserved in a medium containing DMSO. The neurons 
were stored and transported in a cryovial at -196 °Ϲ dry liquid nitrogen tank.  
2.0.1.1 Culture media  
 The neurons cultured using Neurobasal®-medium, GlutaMAXTM- I Supplement 
and B-27® supplement was prepared according to the protocol provided by Gibco™. The 
Gibco™ Antibiotic-Antimycotic was used acts as antibiotic for throughout the cultures. 
L-glutamine was supplemented in the first 4 days of culturing as amino acid supplement 
for neuron culture media. The composition of Neurobasal complete media is showed in 
Table 2.1.  
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Table 2.1 The composition of Neurobasal complete media in 100 mL. 
 
Component Final concentration Volume (mL) 
Neurobasal®-medium 1x 98 
GlutaMAXTM- I Supplement 2 % 2 
B-27® supplement 0.5 mM 0.25 
L-glutamine * 250 µM 0.0625 
Antibiotic-Antimycotic 0.01 % 0.5 
*Only supplemented at the first 4 day of culture
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2.0.2 Chemicals and reagents 
Chemicals and reagents used in the experiment were listed below in Table 2.2.   
Table 2.2 List of chemicals and reagents in the study. 
  
Materials Manufacturer Application  
Ethanol denatured HmbG, Germany  
Cell culture 
 
2-propanaol, ACS Grade for analysis Merck Millipore, USA 
Poly-L-Lysine (PLL) Sigmal-Aldrich®, 
USA 
Paraformaldehyde (PFA) Merck Millipore, USA Immunostaining 
 
 
 
 
 
 
 
Immunostaining 
 
Sodium Chloride, NaCl Riedel-de Haen, 
Denmark 
Sodium Phosphate Monobasic, NaH2PO4 Sigmal-Aldrich
®, USA 
Sodium Phosphate Dibasic, Na2HPO4 Sigmal-Aldrich
®, USA 
Sodium Hydroxide anhydrous, NaOH Sigmal-Aldrich®, USA 
Triton™ X-100 Surfact-Amps™ 
Detergent Solution 
Thermo Scientific, 
USA 
Goat-serum  Thermo Fisher 
Scientific, New 
Zealand  
Prolong Anti-Fade Gold Mounting 
Reagent  
Invitrogen™, USA 
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2.0.3 Reagent preparation  
2.0.3.1 Preparation of KA  
 Serial dilution was performed to obtain 0.5 μM of KA. 10 mL of UltraPure™ 
DNase/RNase-Free Distilled Water was added into the KA monohydrate (10 mg) 
contained vial. The vial was shaken vigorously and vortexed to ensure KA monohydrate 
dissolved thoroughly, concentration of KA solution is 0.04 mM. Then, 12.5 mL of 0.04 
mM of KA was diluted to 10 μM of KA in 50 mL UltraPure™ DNase/RNase-Free 
Distilled Water (refer to Appendix 1 for the calculation). 10 μM of KA was stored at -20 
°Ϲ for subsequent use. On the day of KA treatment, 0.5 μM of KA was freshly prepared 
by diluting 2.5 mL of 10 μM KA solution to 47.5 mL of Neurobasal complete media 
(Bevinahal et al., 2014). 
2.0.3.2 Phosphate buffer (PB) 
Phosphate buffer is prepared according to the proportion of components shown 
in Table 2.3. 800 mL of distilled water was heated to 60 °Ϲ then 2.76 g Sodium 
Phosphate Monobasic (NaH2PO4) and 2.845 g Sodium Phosphate Dibasic (Na2HPO4) 
was added in. The solution is remained heated and stirred until the solution turned clear. 
The solution was then topped up to 1000 mL using deionized distilled water then 
autoclaved and store at 4 ºC for subsequent use. 
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Table 2.3 The composition of PBS. 
Component Gram/Litre 
NaH2PO4 2.76 
Na2HPO4 2.845 
2.0.3.3 Preparation of 4 % Paraformaldehyde (PFA)  
40 g of PFA added into the beaker contained with 400 mL of distilled water at 60 
°Ϲ. Next, a pellet of anhydrous NaOH pellet was added to the solution and stirred until it 
turned colourless. Then, the solution is transferred and filtered into the 1000 mL flat-
bottomed flask using filter funnel. 400 mL of PB is then added into the flat-bottomed 
flask and tested the pH value using pH paper. NaCl and HCl solution were used to 
neutralise the final pH value to pH 7. The solution was topped with deionised distilled 
water to the 1000 mL. The PFA is autoclaved at 121 ºC and then stored at 4 °C for 
subsequent use.  
2.0.3.4 Preparation of 0.3 % Triton X solution  
 150 μL of Triton X was added to 49.85 mL of D-PBS filled stock bottle and 
stored at 4 °C for subsequent use.  
2.0.3.5 Preparation of 5 % goat serum  
 5 mL of goat serum was added into 95 mL of D-PBS filled stock bottle and 
stored at 4 °C for subsequent use.  
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2.0.4 Antibodies  
Primary antibodies and secondary antibodies were used in the experiment. The 
primary antibodies were purchased from Abcam, UK whereas the secondary antibodies 
were purchased from Invitrogen™, USA. The antibodies used are listed as showed in the 
Table 2.4. 
Table 2.4 List of antibodies  
Material Manufacturer Application  
MAP2 Monoclonal Antibody (M13) Invitrogen™, USA  
 
 
 
 
 
 
 
Immunostaining 
 
 
 
 
Anti-GABA A Receptor alpha 1 antibody 
(ab94585) 
Abcam, UK 
Anti-BDNF antibody (ab205067) Abcam, UK 
Anti-TrkB antibody (ab18987) Abcam, UK 
Anti-IP3 receptor antibody (ab5804) Abcam, UK 
DAPI Nucleic Acid Stain Invitrogen™, USA 
Goat anti-Mouse IgG (H+L) Highly 
Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 488 
Invitrogen™, USA 
Goat anti-Mouse IgG (H+L) Highly 
Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 488 
Invitrogen™, USA 
Goat anti-Rabbit IgG (H+L) Highly 
Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 594 
Invitrogen™, USA 
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2.0.5 Buffer solution  
Several buffer solutions were used for different applications. Hank’s Balanced 
Salt Solution was used to rinse the culture plates during PLL coating process whereas 
Dulbecco’s Phosphate Buffered Saline (D-PBS) was used to rinse the cell culture plate 
seeded with neuron during immunostaining processes. The HBSS buffer solution 
provide a favourable condition with relatively higher glucose level compared to D-PBS. 
This reduced the stresses in the neuron and increase the chances of producing a healthier 
neuron culture. Ultrapure™ DNase/RNase-Free Distilled Water was used in PLL cell 
coating and used to fill in water reservoir pan in CO2 incubator. The buffer solutions 
used are listed as below (Table 2.5).   
Table 2.5 List of buffer and solution 
Materials Manufacturer Application  
Hank's Balanced Salt Solution, HBSS Gibco™, USA Cellular work 
Dulbecco's Phosphate-Buffered Saline, D-
PBS) 
Gibco™, USA Cellular work, 
Immunostaining 
UltraPure™ DNase/RNase-Free Distilled 
Water 
Gibco™, USA Cellular work 
2.0.6 Equipment and consumables 
List of equipment and consumables used in the experiments were listed in the 
Table 2.6 as shown below.  
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Table 2.6 List of equipment and consumables 
Equipment Manufacturer Application  
Countess® Automated Cell Counter Invitrogen™, USA  
 
Cellular 
work 
 
CO2 incubator NuAire Inc, USA 
Inverted microscope Carl Zeiss, Germany 
VariosKan 2000 Thermo Fisher Scientific, 
USA 
Confocal Microscope Carl Zeiss, Germany  
Immunostain
ing 
Evos FL Auto 2 Cell Imaging System Thermos Fisher 
Scientific, USA 
Microcentrifuge   
 
 
 
Cellular 
work 
Sorvall Legend Microcentrifuge Thermo Scientific, 
Germany 
Centrifuge 5424 Eppendorf, Germany 
Microspin Eppendorf, Germany 
  
Cultureware Greiner Bio-One, Austria 
 6-well plate 
96-well plate 
Glass coverslip, 25mm2 (round) 
Filter paper Sigmal-Aldrich®, USA 
Countess® Cell Counting Chamber Slides Invitrogen™, USA 
Centrifuge tube  
Greiner Bio-One, Austria 50mL centrifuge tube 
15mL centrifuge tube 
1.5mL microcentrifuge tube 
